Erratum for “Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma—a Pediatric Brain Tumor Consortium study”

by Gururangan et al. Neuro Oncol (2012) 14(11): 1404–1412 doi:10.1093/neuonc/nos213

Dr. Roger McLendon, who provided an important contribution to this work in the form of pathology review and immunohistochemistry assessment of biologic makers was accidentally not included in the co-author list. The co-authors of this article regret and apologize for this error.